We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01653860
Previous Study | Return to List | Next Study

Partner Violence and Anger Management

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01653860
Recruitment Status : Completed
First Posted : July 31, 2012
Last Update Posted : November 3, 2020
Sponsor:
Collaborators:
St. Olavs Hospital
Karolinska Institutet
Information provided by (Responsible Party):
Norwegian University of Science and Technology

Brief Summary:

The purpose of this study is to investigate the effectiveness of the Brøset anger management model in reducing violent behavior amongst clients who are violent in intimate partnerships and who voluntarily seek help.

Violence in intimate partnerships constitutes a serious problem worldwide and there is reason to believe that cognitive behavior therapy has some effect on the reduction of violent behavior. However, there are currently too few randomized controlled studies to conclude about the effectiveness of cognitive behavior therapy for this client group.


Condition or disease Intervention/treatment Phase
Domestic Violence Spouse Abuse Behavioral: The Brøset anger management model Behavioral: Ordinary group treatment Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 185 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Partner Violence and Anger Management: a Randomised Controlled Study of the Effectiveness of Cognitive Behavioral Therapy
Actual Study Start Date : July 2012
Actual Primary Completion Date : May 4, 2018
Actual Study Completion Date : May 4, 2018

Arm Intervention/treatment
Experimental: The Brøset anger management model
Group treatment
Behavioral: The Brøset anger management model
manualised structured cognitive treatment program 15 weeks (30 hours)

Active Comparator: ordinary group treatment
Group treatment
Behavioral: Ordinary group treatment
group treatment 8 weeks (16 hours)




Primary Outcome Measures :
  1. violent behaviour, reported by partner and client [ Time Frame: 3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol. ]
    measured by using the Conflict Tactics Scale Revised (CTS2), instrument for measuring violence in intimate partnerships(10), which consists of 78 questions (0-7) about different aspects of violence (frequence of physical, psychological, sexual and material violence)


Secondary Outcome Measures :
  1. The client's and their partner's mental health [ Time Frame: 3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol. ]
    measured by using the Hopkins Symptoms Check List (HSCL-25, with 25 questions about the presence and intensity of anxiety and depression symptoms, and symptoms of somatoform character)

  2. The client's and their partner's health service use and absence due to sickness [ Time Frame: 3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol. ]
  3. Changes in emotional dysregulation [ Time Frame: 3 months between assessments, 1 year duration, i.e. baseline and 4 follow-up assessments. In accordance with the original Norwegian protocol. ]
    Emotional regulation will be assessed by the Difficulties in Emotion Regulation Scale (DERS, Gratz & Roemer, 2004).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • fluent in Norwegian language
  • is in a partner relationship at inclusion. Partner relationship is defined by having an intimate partner at present, or being in regular contact with a former intimate partner so that violence is possible (e.g. they have children)
  • admits being violent to his partner (physical, mental and/or sexual)

Exclusion Criteria:

  • psychosis
  • alcohol- or drug addiction to a level that hinders group participation free from intoxication.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01653860


Locations
Layout table for location information
Norway
St Olavs University Hospital, Division of Psychiatry, Centre for research and education in forensic psychiatry Brøset
Trondheim, Norway, 7440
Sponsors and Collaborators
Norwegian University of Science and Technology
St. Olavs Hospital
Karolinska Institutet
Investigators
Layout table for investigator information
Principal Investigator: Tom Palmstierna, MD PhD prof Norwegian University of Science and Technology
Publications of Results:
Layout table for additonal information
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT01653860    
Other Study ID Numbers: 2012/683
First Posted: July 31, 2012    Key Record Dates
Last Update Posted: November 3, 2020
Last Verified: November 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Norwegian University of Science and Technology:
Behavior therapy
Group therapy